510(k) device
Qbtest
Qbtech AB · Recorder, Attention Task Performance (LQD, Unclassified) · First FDA decision Jun 22, 2004, newest Jun 22, 2004ADHD
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
1
Naming "Qbtest"
MAUDE reports
0
Brand "Qbtest", since 2015
PubMed studies
60
Mentioning "Qbtest"
AI summary across all sources
Written by Claude (Anthropic's AI) from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- QBTEST510(k)
K040894 · Decided Jun 22, 2004 · 77 days after receipt
Device type: Recorder, Attention Task Performance (LQD) · Neurology & Neurosurgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Qbtest", any status and sponsor, newest update first.
Nottinghamshire Healthcare NHS TrustGovernment (non-federal)
NCT03368573 · 43 participants · Start Dec 1, 2017 · Primary completion Mar 31, 2018
Device: QbTest · For: ADHD
Sites: Nottingham, United Kingdom
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Qbtest", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code LQD
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Qbtest"[tiab]. The summary above synthesizes these.
- Monitoring medication response in ADHD: what can continuous performance tests tell us?
Cedergren K, Östlund S, Åsberg Johnels J, et al. · Eur Arch Psychiatry Clin Neurosci · 2022
- The Structure and Diagnostic Accuracy of the QbTest in Pediatric ADHD: A Retrospective Clinical Study.
Stevanovic D, Nasic S, Doric A, et al. · J Atten Disord · 2023Research Support, Non-U.S. Gov't
- A national evaluation of QbTest to support ADHD assessment: a real-world, mixed methods approach.
Hall SS, McKenzie C, Thomson L, et al. · BMC Health Serv Res · 2024
- QbTest for Monitoring Medication Treatment Response in ADHD: A Systematic Review.
Gustafsson U, Hansen M · Clin Pract Epidemiol Ment Health · 2023Systematic Review
- Practitioner Review: Clinical utility of the QbTest for the assessment and diagnosis of attention-deficit/hyperactivity disorder - a systematic review and meta-analysis.
Bellato A, Hall CL, Groom MJ, et al. · J Child Psychol Psychiatry · 2024Systematic Review, Meta-Analysis
- The Quantified Behavioral Test Failed to Differentiate ADHD in Adolescents With Neurodevelopmental Problems.
Johansson V, Norén Selinus E, Kuja-Halkola R, et al. · J Atten Disord · 2021Research Support, Non-U.S. Gov't
- The Impact of Methylphenidate on QbTest Performance of Children with ADHD: A Retrospective Clinical Study.
Knez R, Stevanovic D, Nasic S, et al. · Neuropsychiatr Dis Treat · 2021
- Behavioral Assessment of Core ADHD Symptoms Using the QbTest.
Reh V, Schmidt M, Lam L, et al. · J Atten Disord · 2015
- Efficacy of Continuous Performance Testing in Adult ADHD in a Clinical Sample Using QbTest.
Adamou M, Jones SL, Marks L, et al. · J Atten Disord · 2022
- Using an objective computer task (QbTest) to aid the identification of attention deficit hyperactivity disorder (ADHD) in the Children and Young People Secure Estate (CYPSE): a feasibility randomised controlled trial.
Chitsabesan P, Hall CL, Carter LA, et al. · BMJ Open · 2022Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- ASD with ADHD vs. ASD and ADHD alone: a study of the QbTest performance and single-dose methylphenidate responding in children and adolescents.
Stevanovic D, Wentz E, Nasic S, et al. · BMC Psychiatry · 2022Research Support, Non-U.S. Gov't
- QbTest for ADHD assessment and medication management: a mixed-methods systematic review of impact on clinical outcomes and patient, carer and clinician experiences.
Tomlinson E, Owen-Smith A, Benavente M, et al. · BMJ Open · 2025Systematic Review
Other devices of this type
Also filed under product code LQD.
- Test of Variables of Attention (T.O.V.A.)The Tova Company · 510(k) 2018
- QbCheckQbtech AB · 510(k) 2016
- DanaAnthrotronix, Inc. · 510(k) 2014
- Qb TestQbtech AB · 510(k) 2014
- QbtesQbtech AB · 510(k) 2012
- Optax SystemOptax Systems, Inc. · 510(k) 2002
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.